Pulmonx (LUNG) Change in Accured Expenses (2019 - 2025)

Pulmonx (LUNG) has 7 years of Change in Accured Expenses data on file, last reported at $528000.0 in Q3 2025.

• Quarterly Change in Accured Expenses fell 27.87% year-over-year to $528000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.1 million (up 269.71% YoY) and the FY2024 annual result came in at $462000.0, down 85.45% from the prior year.
• Change in Accured Expenses fell to $528000.0 in Q3 2025 per LUNG's latest filing, from $2.5 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $4.0 million in Q4 2024 and bottomed at -$6.0 million in Q1 2024.
• The 5-year median for Change in Accured Expenses is $1.0 million (2022), against an average of $355315.8.
• The widest annual swing landed in 2021, when Change in Accured Expenses jumped 237.32%; it then tumbled 357.53% in 2022.
• Tracing LUNG's Change in Accured Expenses over 5 years: stood at $1.5 million in 2021, then surged by 58.05% to $2.4 million in 2022, then declined by 5.53% to $2.3 million in 2023, then surged by 76.48% to $4.0 million in 2024, then plunged by 86.72% to $528000.0 in 2025.
• Per Business Quant, the three latest LUNG Change in Accured Expenses figures stand at $528000.0 (Q3 2025), $2.5 million (Q2 2025), and -$4.9 million (Q1 2025).

Peer Comparison